Few Promising Ebola Drugs In Development, WHO Says; Canada Begins Domestic Trial Of Test Vaccine

News outlets report on various aspects of Ebola vaccine and treatment development.

Agence France-Presse: Very few drugs, trial sites in search for Ebola cure: WHO (Larson, 11/14).
Associated Press: WHO sees few promising Ebola drugs in pipeline (11/14).
Bloomberg News: Ebola Vaccine Challenge: Motorbikes and Kerosene Fridges (Kitamura, 11/16).
The Economist: Unchained malady (11/15).
Reuters: WHO starts survey of Ebola treatments, says none proven so far (Miles, 11/14).
Reuters: No safety concerns yet in trials of GSK’s Ebola vaccine (Kelland, 11/17).
TIME: WHO: These Are the Most Promising Ebola Treatments (Park, 11/14).
VOA News: WHO Sets Clinical Trial Criteria for Ebola Drugs (Schlein, 11/14).
Agence France-Presse: Canada to begin Ebola vaccine trials (11/14).
Reuters: Canada begins domestic trial of experimental Ebola vaccine (Hodgson, 11/14).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.